Sign in to view content

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema

Victor Hugo Gonzalez, MD

Video
Published 2024

Related

Severe Vision Loss After Intravitreal Injections of Autologous Adipose Tissue-derived Stem Cells for Age-Related Macular
Ajay E Kuriyan, MD, MS
Updates from the Field
2016
TIE2, VEGF, and Integrin Receptor Interplay and its Role in Retinal Disease
Peter K. Kaiser, MD FASRS
Updates from the Field
2020
Imaging Signatures and Cytokine Expression in Diabetic Macular Edema From the IMAGINE Study: Biomarker Exploration for Precision Medicine
Sruthi Arepalli, MD
On Demand Cases, Courses, and Papers
2020

Category: Diabetic Retinopathy

See more